The good and the bad effects of (−) trans-delta-9-tetrahydrocannabinol (Δ9-THC) on humans
- 3 July 2004
- journal article
- review article
- Published by Elsevier
- Vol. 44 (4) , 461-467
- https://doi.org/10.1016/j.toxicon.2004.05.009
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Endogenous cannabinoid system as a modulator of food intakeInternational Journal of Obesity, 2003
- Biomedical benefits of cannabinoids?Addiction Biology, 1999
- Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexiaJournal of Pain and Symptom Management, 1997
- Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDSJournal of Pain and Symptom Management, 1995
- Delta-9-THC in the Treatment of Spasticity Associated with Multiple SclerosisAdvances in Alcohol & Substance Abuse, 1988
- Clinical Relevance of Cannabis Tolerance and DependenceThe Journal of Clinical Pharmacology, 1981
- Hypnotic and Antiepileptic Effects of CannabidiolThe Journal of Clinical Pharmacology, 1981
- Treatment of Human Spasticity with Δ9‐TetrahydrocannabinolThe Journal of Clinical Pharmacology, 1981
- Anticonvulsant nature of marihuana smokingPublished by American Medical Association (AMA) ,1975
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964